Brevel: Funding, Investors & Team (Sep 2026)
Brevel has created an innovative method of cultivating microalgae that is both sustainable and cost-effective, while also producing high-quality output for a range of markets that have yet to be explored. This technology utilizes advanced indoor systems that are sterile and fully automated, with intense internal illumination. As a result, Brevel has achieved remarkable results, including a cost reduction of over 90% and yields that are up to 200 times higher than existing alternatives. Leveraging these production capabilities, Brevel is now venturing into various markets that require products derived from microalgae.
Brevel has raised $24.5M across 4 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Brevel Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Brevel Funding Rounds
Brevel raised $8.4M in a Seed announced in Jun 2022.
1.1 years later, a Seed of $10.1M was announced in Jul 2023.
1.7 years later, a Seed of $5.0M was announced in Mar 2025.
1.3 years later, an undisclosed round of $1.0M was announced in Jun 2026.
Brevel Founders and Leadership Team
Contact details for the Brevel team: 1 of 1 has an email address on file.
Start 14-day free trial →Brevel Funding Compared to Other Biotechnology Startups
Brevel's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Brevel in Biotechnology and Shekef
Companies Similar to Brevel
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and…
Brevel Funding FAQs
What does Brevel do?
Brevel has created an innovative method of cultivating microalgae that is both sustainable and cost-effective, while also producing high-quality output for a range of markets that have yet to be explored. This technology utilizes advanced indoor systems that are sterile and fully automated, with intense internal illumination. As a result, Brevel has achieved remarkable results, including a cost reduction of over 90% and yields that are up to 200 times higher than existing alternatives. Leveraging these production capabilities, Brevel is now venturing into various markets that require products derived from microalgae.
How much funding has Brevel raised?
Brevel has raised $24.5M across 4 rounds on record. The most recent is an undisclosed round of $1.0M announced in Jun 2026.
When did Brevel last raise funding?
Brevel's most recent funding round on record is an undisclosed round of $1.0M, announced in Jun 2026.
Who is the CEO of Brevel?
Yonatan Golan is listed as CEO at Brevel.
Where is Brevel headquartered?
Brevel is based in Shekef, Hadarom, Israel.
How many employees does Brevel have?
Brevel is in the 11-50 employee band.
How does Brevel's funding compare to other Biotechnology startups?
Brevel's latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Brevel Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Brevel is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.